Expression, crystallization and preliminary crystallographic study of human coronavirus HKU1 nonstructural protein

  • 0 0 0
  • Like this paper and download? You can publish your own PDF file online for free in a few minutes! Sign Up

Expression, crystallization and preliminary crystallographic study of human coronavirus HKU1 nonstructural protein

crystallization communications Acta Crystallographica Section F Structural Biology and Crystallization Communications

576 30 360KB

Pages 3 Page size 609.675 x 793.701 pts Year 2009

Report DMCA / Copyright

DOWNLOAD FILE

Recommend Papers

File loading please wait...
Citation preview

crystallization communications Acta Crystallographica Section F

Structural Biology and Crystallization Communications

Expression, crystallization and preliminary crystallographic study of human coronavirus HKU1 nonstructural protein 9

ISSN 1744-3091

Wei Wang,a Lei Wei,a Anqi Yang,a Teng He,a K. Y. Yuen,b Cheng Chena* and Zihe Raoa,c a

Tsinghua–Nankai–IBP Joint Research Group for Structural Biology, Tsinghua University, Beijing 100084, People’s Republic of China, b Laboratory of Avian Medicine, College of Veterinary Medicine, South China Agricultural University, Guangzhou 510642, People’s Republic of China, and cNational Laboratory of Macromolecules, Institute of Biophysics, Chinese Academy of Science, Beijing 100101, People’s Republic of China

Correspondence e-mail: [email protected]

Received 2 December 2008 Accepted 15 April 2009

Human coronavirus HKU1 (HCoV-HKU1) belongs to coronavirus group II and encodes 16 nonstructural proteins (nsps) which mediate genome replication and transcription. Among these nsps, nsp9 has been shown to possess singlestranded DNA/RNA-binding properties. The gene that encodes HCoV-HKU1 nsp9 was cloned and expressed in Escherichia coli and the protein was subjected ˚ resolution and belonged to crystallization trials. The crystals diffracted to 2.7 A ˚, to space group P21212, with unit-cell parameters a = 83.5, b = 88.4, c = 31.2 A   =  =  = 90 and two molecules per asymmetric unit.

1. Introduction Since the global outbreak of SARS coronavirus in 2003, which caused 750 deaths in over 8000 patients, several novel human coronaviruses (HCoVs) have been discovered, one of which is human coronavirus HKU1 (HCoV-HKU1; Woo, Huang et al., 2005). HKU1 is a member of the genus Coronavirus, which can be classified into three distinct groups (Spaan & Cavanagh, 2004). Like SARS, HKU1 also belongs to coronavirus group II and infects humans (Gerna et al., 2007). Patients infected by HKU1 have been reported worldwide, including in Korea (Choi et al., 2006), North America (Esper et al., 2006), Australia (Sloots et al., 2006) and Europe (Bosis et al., 2007) and often exhibit self-limiting syndromes in the lower respiratory tract (Zhao et al., 2008). Genome-sequencing research showed that HKU1 shares high sequence homology with mouse hepatitis virus (MHV; Woo, Huang et al., 2005), another group II coronavirus. The HKU1 genome is a single-stranded positive-sense polyadenylated RNA of 29 926 nucleotides. In common with other coronaviruses, this genome contains two large ORFs (ORFs 1a and 1b) that are required for RNA transcription and genome replication and that are processed into 16 nonstructural proteins by virusencoded proteinases (Snijder et al., 2003; Prentice et al., 2004; Woo, Lau et al., 2005). Nsp9 has been shown to be essential for viral RNA synthesis and replication based on deletion experiments in MHV (Deming et al., 2007). The presence of two molecules of nsp9 per asymmetric unit may indicate that the protein functions as a dimer, as is the case for SARS-CoV nsp9 (Campanacci et al., 2003). Based on available structural data, nsp9 has been proposed to possess the function of stabilizing nascent nucleic acids during RNA synthesis and participating in such base-pairing-driven processes based on its single-stranded RNA-binding properties (Egloff et al., 2004).

2. Expression and purification

# 2009 International Union of Crystallography All rights reserved

526

doi:10.1107/S1744309109014055

The cDNA encoding HCoV-HKU1 nsp9 was provided by Professor K. Y. Yuen (Department of Microbiology, Hong Kong University, HKSAR, China). The gene encoding HKU1 nsp9 (corresponding to Asn4211–Gln4320, where the numbering is that of the entire polyprotein) was amplified by the PCR method using forward and reverse primers 50 -CGGGATCCAATAATGAGTTGATGCCT-30 and 50 -CCGCTCGAGTTACTGCAATCTAATTGTTG-30 , respectively, and then inserted between the BamHI and XhoI sites of the pGEX-6p-1 plasmid. After verifying the sequence, the recombinant plasmid was Acta Cryst. (2009). F65, 526–528

crystallization communications transformed into Escherichia coli BL21 (DE3). Cultures were grown in LB medium containing 0.1 mg ml1 ampicillin at 310 K until the optical density at 600 nm (OD600) reached 0.6. 0.5 mM isopropyl -d1-thiogalactopyranoside (IPTG) was added and the cultures were induced to express HKU1 nsp9 at 289 K for 16 h. Centrifugation was used to harvest the cells and the bacterial pellets were resuspended in PBS (140 mM NaCl, 10 mM Na2HPO4, 2.7 mM KCl, 1.8 mM KH2PO4 pH 7.3) supplemented with 1 mM DTT. After sonication at 277 K, the lysate was centrifuged at 12 000g for 50 min at 277 K and the precipitate was discarded. The supernatant was loaded onto a GSTglutathione affinity column (Pharmacia). The fusion protein was then cleaved on the column by GST-rhinovirus 3C protease at 277 K for 18 h; five additional residues (GPLGS) were left at the N-terminus of HKU1 nsp9. The cleavage buffer of the protease was PBS and the ratio of protease to protein was approximately 1:50. Thermo iCON concentrators were used to concentrate the protein. After concentration using a Thermo Centra-CL3R, a Superdex 75 column (GE

Healthcare) was used to purify the HKU1 nsp9 in a buffer containing 20 mM MES, 150 mM NaCl pH 6.0. Typical yields were 3 mg of purified protein per litre of bacterial culture.

3. Crystallization After purification, the HKU1 nsp9 protein was concentrated to 25 mg ml1 in a buffer containing 150 mM NaCl, 20 mM MES pH 6.0. Crystal Screen reagent kits (Hampton Research) were used to screen for conditions for crystallization. We performed crystal screening using the vapour-diffusion technique at 291 K in 16-well crystallization plates. 1.0 ml protein solution was mixed with 1.0 ml reservoir solution and then left to reach equilibrium while hanging over 400 ml reservoir solution. Initial crystals of HKU1 nsp9 were obtained using condition No. 40 from Hampton Research Crystal Screen 1, which contained 0.1 M sodium citrate tribasic dehydrate pH 5.6, 20%(v/v) 2-propanol, 20%(w/v) polyethylene glycol 4000. The optimized condition contained 0.12 M sodium citrate tribasic dehydrate pH 5.6, 20%(v/v) 2-propanol, 25%(w/v) polyethylene glycol 4000 (Fig. 1).

4. Data collection and processing

Figure 1 Typical crystals of HKU1 nsp9 grown by the hanging-drop method in 0.1 M sodium citrate tribasic dehydrate pH 5.6, 20%(v/v) 2-propanol, 20%(w/v) polyethylene glycol 4000. Typical crystal dimensions are 0.3  0.03  0.04 mm.

The crystal was directly mounted in a nylon loop and flash-cooled in a nitrogen stream at 100 K using an Oxford Cryosystems cryostream. The diffraction data were collected in-house on a Rigaku Cu K rotating-anode X-ray generator (MM-007) at 40 kV and 20 mA ˚ ) with a Rigaku R-AXIS IV++ image-plate detector. Data (1.5418 A were processed, integrated, scaled and merged using the HKL-2000 programs DENZO and SCALEPACK (Otwinowski & Minor, 1997). ˚ resolution (Fig. 2). They belonged to The crystals diffracted to 2.7 A space group P21212, with unit-cell parameters a = 83.5, b = 88.4, ˚ ,  =  =  = 90 . Based on the molecular weight of the c = 31.2 A monomer, the Matthews coefficient (Matthews, 1968) was calculated

Figure 2 A typical diffraction pattern of an HKU1 nsp9 crystal collected on a Rigaku R-AXIS IV++ image-plate detector.

Acta Cryst. (2009). F65, 526–528

Wang et al.



Human coronavirus HKU1 nonstructural protein 9

527

crystallization communications References

Table 1 Data-collection and processing statistics. Values in parentheses are for the highest resolution shell. ˚) Wavelength (A ˚) Resolution (A Space group ˚ , ) Unit-cell parameters (A Rmerge† (%) ˚ 3 Da1) Matthews coefficient (A Solvent content (%) Average I/(I) Completeness (%) Redundancy No. of observed reflections No. of unique reflections Molecules per ASU

1.5418 50.0–2.7 (2.8–2.7) P21212 a = 83.5, b = 88.4, c = 31.2,  =  =  = 90 7.9 (43.6) 2.35 47.77 17.4 (2.1) 97.1 (91.0) 5.5 (4.3) 37325 6738 2

P P P P † Rmerge = hkl i jIi ðhklÞ  hIðhklÞij= hkl i Ii ðhklÞ, where Ii(hkl) is an individual intensity measurement and hI(hkl)i is the average intensity for all the reflections i.

˚ 3 Da1 and the solvent content was 47.77%, assuming the to be 2.35 A presence of two molecules per asymmetric unit. Data-collection statistics are shown in Table 1. Further structural and functional analysis of HKU1 nsp9 will reveal the conserved structural and functional aspects that are common to the different groups that make up the coronavirus family.

This work was supported by Project 973 of the Ministry of Science and Technology of China (grant No. 2006CB914301) and the National Natural Science Foundation of China (NSFC; grant Nos. 30221003 and 30730022).

528

Wang et al.



Human coronavirus HKU1 nonstructural protein 9

Bosis, S., Esposito, S., Niesters, H. G., Tremolati, E., Pas, S., Principi, N. & Osterhaus, A. D. (2007). J. Clin. Virol. 38, 251–253. Campanacci, V., Egloff, M.-P., Longhi, S., Ferron, F., Rancurel, C., Salomoni, A., Durousseau, C., Tocque, F., Bre´mond, N., Dobbe, J. C., Snijder, E. J., Canard, B. & Cambillau, C. (2003). Acta Cryst. D59, 1628–1631. Choi, E. H., Lee, H. J., Kim, S. J., Eun, B. W., Kim, N. H., Lee, J. A., Lee, J. H., Song, E. K., Kim, S. H., Park, J. Y. & Sung, J. Y. (2006). Clin. Infect. Dis. 43, 585–592. Deming, D. J., Graham, R. L., Denison, M. R. & Bar, R. S. (2007). J. Virol. 81, 10280–10291. Egloff, M.-P., Ferron, F., Campanacci, V., Longhi, S., Rancurel, C., Dutartre, H., Snijder, E. J., Gorbalenya, A. E., Cambillau, C. & Canard, B. (2004). Proc. Natl Acad. Sci. USA, 101, 3792–3796. Esper, F., Weibel, C., Ferguson, D., Landry, M. L. & Kahn, J. S. (2006). Emerg. Infect. Dis. 12, 775–779. Gerna, G., Percivalle, E., Sarasini, A., Campanini, G., Piralla, A., Rovida, F., Genini, E., Marchi, A. & Baldanti, F. (2007). J. Clin. Virol. 38, 244–250. Matthews, B. W. (1968). J. Mol. Biol. 33, 491–497. Otwinowski, Z. & Minor, W. (1997). Methods Enzymol. 276, 307–326. Prentice, E., McAuliffe, J., Lu, X., Subbarao, K. & Denison, M. R. (2004). J. Virol. 78, 9977–9986. Sloots, T. P., McErlean, P., Speicher, D. J., Arden, K. E., Nissen, M. D. & Mackay, I. M. (2006). J. Clin. Virol. 35, 99–102. Snijder, E. J., Bredenbeek, P. J., Dobbe, J. C., Thiel, V., Ziebuhr, J., Poon, L. L. M., Guan, Y., Rozanov, M., Spaan, W. J. M. & Gorbalenya, A. E. (2003). J. Mol. Biol. 331, 991–1004. Spaan, W. J. M. & Cavanagh, D. (2004). Virus Taxonomy. VIIIth Report of the ICTV, pp. 945–962. London: Elsevier/Academic Press. Woo, P. C., Huang, Y., Lau, S. K., Tsoi, H. W. & Yuen, K. Y. (2005). Microbiol. Immunol. 49, 899–908. Woo, P. C., Lau, S. K., Chu, C. M., Chan, K. H., Tsoi, H. W., Huang, Y., Wong, B. H., Poon, R. W., Cai, J. J., Luk, W. K., Poon, L. L., Wong, S. S., Guan, Y., Peiris, J. S. & Yuen, K. Y. (2005). J. Virol. 79, 884–895. Zhao, Q., Li, S., Xue, F., Zou, Y., Chen, C., Bartlam, M. & Rao, Z. (2008). J. Virol. 82, 8647–8655.

Acta Cryst. (2009). F65, 526–528